Filing Details
- Accession Number:
- 0001127602-14-027224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-04 18:13:20
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-04
- Accepted Time:
- 2014-09-04 17:13:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238327 | William Abraham | C/O Conmed Corp 525 French Road Utica NY 13502 | Evp-Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-02 | 10,000 | $31.40 | 11,486 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 10,000 | $39.76 | 1,486 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 2,500 | $19.93 | 3,986 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 1,702 | $39.89 | 2,284 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 2,500 | $29.92 | 4,784 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 2,102 | $39.89 | 2,682 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 2,500 | $26.69 | 5,182 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 1,972 | $39.89 | 3,210 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 5,000 | $16.46 | 8,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 3,124 | $39.89 | 5,086 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 4,000 | $19.26 | 9,086 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 2,679 | $39.89 | 6,407 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 3,000 | $27.63 | 9,407 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 2,411 | $39.89 | 6,996 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 2,000 | $26.09 | 8,996 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 1,559 | $39.89 | 7,437 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-09-03 | 1,000 | $32.93 | 8,437 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-03 | 889 | $39.89 | 7,548 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-09-04 | 6,062 | $40.16 | 1,486 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2014-09-02 | 10,000 | $0.00 | 10,000 | $31.40 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 2,500 | $0.00 | 2,500 | $19.93 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 2,500 | $0.00 | 2,500 | $29.92 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 2,500 | $0.00 | 2,500 | $26.69 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 5,000 | $0.00 | 5,000 | $16.46 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 4,000 | $0.00 | 4,000 | $19.26 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 3,000 | $0.00 | 3,000 | $27.63 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 2,000 | $0.00 | 2,000 | $26.09 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2014-09-03 | 1,000 | $0.00 | 1,000 | $32.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-11-17 | 2015-05-17 | No | 4 | M | Direct |
| 0 | 2016-05-16 | No | 4 | M | Direct | |
| 0 | 2017-05-17 | No | 4 | M | Direct | |
| 0 | 2018-06-01 | No | 4 | M | Direct | |
| 0 | 2019-06-01 | No | 4 | M | Direct | |
| 1,000 | 2020-06-01 | No | 4 | M | Direct | |
| 2,000 | 2021-06-01 | No | 4 | M | Direct | |
| 3,000 | 2022-06-01 | No | 4 | M | Direct | |
| 4,000 | 2023-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
- The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Billionaire Hedge Funds
